Saljoghi R, Le Vourch A, Renard B, Villers A, Bouyé S
Hôpital Claude Huriez, CHRU Lille, rue Michel Polonowski, 59000 Lille, France; Centre hospitalier Valenciennes, avenue Desandrouin, 59300 Valenciennes, France.
Hôpital Claude Huriez, CHRU Lille, rue Michel Polonowski, 59000 Lille, France.
Prog Urol. 2019 Sep;29(10):482-489. doi: 10.1016/j.purol.2019.07.005. Epub 2019 Aug 2.
This study aims at providing a retrospective assessment of the decrease in renal volume after renal artery embolization (RAE) among a group of patients with autosomal dominant polycystic renal disease and for whom transplantation, for ergonomic reasons was temporarily advised against.
Between November 2014 and March 2017, as part of pre-transplantory procedure 15 patients, including 11 men and 4 women benfited from renal embolization (RAE) in a context of preparation for transplant in Lille University Hospital. All of the patients were suffering from autosomal dominant polycystic renal disease (ADPKD) at a severe or terminal stage of renal disease.
The original mean total kidney volume (TKV) was 2550.6 cm±1771 (1102 cm; 7310 cm), the average TKV at 3 months was 1684 cm±1539 (648 cm; 6930 cm) with an average decrease of 33% in the volume (5.2%; 83.9%) (95% confidence interval [0.229-0.436]) (P<0.01) and 1632±1743 (599 cm; 6758 cm) at 6 months with an average decrease of 40.7% (7.6%; 64.1%) (IC95% 0.306-0.508) (P<0.01). Among the 15 patients, 13 had their contraindication removed and to date 7 have had successful transplants. One failure due to a very high initial volume (7310cm) required a secondary nephrectomy. No post-embolization syndrome has been noticed, 2 minor complications occurred (13%) involving a difficult resumption of transit and there was one case of hematuria.
ERA procedures must have a place in the ergonomic transplant strategy of patients with ADPKD with a low complication rate and a high efficiency. Nephrectomy indications before transplantation must therefore be reconsidered due to a major postoperative risk. Our results are in line with larger scale studies. Nevertheless, these results need to be confirmed by a large-scale randomized prospective study.
本研究旨在对一组常染色体显性遗传性多囊肾病患者在肾动脉栓塞术(RAE)后肾体积减小情况进行回顾性评估,这些患者因人体工程学原因被暂时建议不宜进行移植手术。
2014年11月至2017年3月期间,作为移植前程序的一部分,里尔大学医院有15例患者(包括11名男性和4名女性)在准备移植的情况下接受了肾栓塞术(RAE)。所有患者均患有处于严重或终末期肾病阶段的常染色体显性遗传性多囊肾病(ADPKD)。
最初的平均总肾体积(TKV)为2550.6 cm±1771(1102 cm;7310 cm),3个月时的平均TKV为1684 cm±1539(648 cm;6930 cm),体积平均减小33%(5.2%;83.9%)(95%置信区间[0.229 - 0.4,36])(P<0.01),6个月时为1632±1743(599 cm;6758 cm),平均减小40.7%(7.6%;64.1%)(95%置信区间0.306 - 0.508)(P<0.01)。15例患者中,13例的移植禁忌被解除,迄今为止7例已成功进行移植。1例因初始体积非常大(7310 cm)导致移植失败,需要进行二次肾切除术。未观察到栓塞后综合征,发生了2例轻微并发症(13%),涉及排便恢复困难,还有1例血尿。
肾动脉栓塞术在ADPKD患者人体工程学移植策略中应有一席之地,其并发症发生率低且效率高。因此,鉴于术后风险较大,移植前肾切除术的指征必须重新考虑。我们的结果与大规模研究一致。然而,这些结果需要通过大规模随机前瞻性研究来证实。
4级。